Publication | Closed Access

Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Neuro-oncologyRadiation MedicineRadiation TherapyMedicineAdjuvant TemozolomideHigh-grade GliomasPhase 2Radiation OncologyOncologyGliomaClinical Radiation OncologyRadiologyHealth Sciences